|[July 01, 2014]
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Fraud Claims Against STAAR Surgical Company
NEW YORK --(Business Wire)--
The Rosen Law Firm, P.A. announces that it is investigating potential
securities fraud claims against STAAR Surgical Company (NASDAQ:STAA)
resulting from allegations that the Company may have made false and
misleading disclosures concerning its business operations and prospects.
On July 1, 2014, the U.S. Food and Drug Administration ("FDA") released
publicly a warning letter it had sent to STAAR Surgical on May 21, 2014.
The warning letter stated that the Company's Monrovia, California
facility lacks adequate procedures for documenting design of implantable
lenses for the eye. The FDA also cited failures in handling complints,
sterility testing, and keeping required records. The FDA's findings stem
from inspections in February-March 2014.
The Rosen Law Firm is preparing a class action lawsuit on behalf of
STAAR Surgical investors. If you purchased STAAR Surgical securities
prior to July 1, 2014, you may visit the website at http://rosenlegal.com
to join the action. You may also contact Phillip Kim, Esq. or Kevin
Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail
at firstname.lastname@example.org or email@example.com.
The Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and shareholder
Attorney Advertising. Prior results do not guarantee a similar outcome.
[ Back To Technology News's Homepage ]